About the Transplant Diagnostics Market Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. Technavio’s analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories. The market is divided into the... Research Beam Model: Research Beam Product ID: 571147 2500 USD New
Global Transplant Diagnostics Market 2016-2020
 
 

Global Transplant Diagnostics Market 2016-2020

  • Category : Consumer Goods
  • Published On : May   2016
  • Pages : 81
  • Publisher : Technavio
 
 
 
About the Transplant Diagnostics Market

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
Technavio’s analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Transplant Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Bio-Rad Laboratories
• CareDx
• Illumina
• Immucor
• Linkage Biosciences
• Thermo Fisher Scientific

Other prominent vendors
• Abbott Laboratories
• Becton
• Dickinson
• Danaher
• F. Hoffmann-La Roche
• HistoGenetics
• Ortho Clinical Diagnostics
• Oxford Immunotec
• Qiagen
• Siemens
• Sigma-Aldrich
• Tosoh Bioscience

Market driver
• Public awareness of organ donation
• For a full, detailed list, view our report

Market challenge
• Limited technical expertise
• For a full, detailed list, view our report

Market trend
• Product approvals and launches
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
• Global transplant diagnostics market by molecular assays
• Global transplant diagnostics market by non-molecular assays
PART 06: Market segmentation by screening
• Pre-transplant diagnostics
• Post-transplant diagnostics
PART 07: Market segmentation by product
• Reagents and consumables
• Instruments
PART 08: Market segmentation by end-user
PART 09: Market segmentation by application
• Stem cell transplantation
• Organ transplantation
PART 10: Geographical segmentation
• Transplant diagnostics market in Americas
• Transplant diagnostics market in EMEA
• Transplant diagnostics market in APAC
PART 11: Market drivers
• Prevalence of chronic diseases
• Public awareness of organ donation
• Growth opportunities in emerging markets
PART 12: Impact of drivers
PART 13: Market challenges
• Unfavorable reimbursement scenario
• Limited technical expertise
• High cost of transplant diagnostics
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Advances in technology
• Government initiatives
• Product approvals and launches
• Increase in M&A
PART 16: Vendor landscape
• Competitive scenario
PART 17: Major vendors
• Bio-Rad Laboratories
• CareDx
• Illumina
• Immucor
• Linkage Biosciences
• Thermo Fisher Scientific
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of HLA testing used to determine compatibility
Exhibit 03: Global transplant diagnostics market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global transplant diagnostics market segmentation by technique
Exhibit 06: Global transplant diagnostics market segmentation by technique 2015
Exhibit 07: Global transplant diagnostics market segmentation by technique 2020
Exhibit 08: PCR techniques: Advantages and disadvantages
Exhibit 09: Global transplant diagnostics market by molecular assays 2015-2020 ($ millions)
Exhibit 10: Global transplant diagnostics market by non-molecular assays 2015-2020 ($ millions)
Exhibit 11: Global transplant diagnostics market segmentation by screening 2015
Exhibit 12: Global transplant diagnostics market segmentation by screening 2020
Exhibit 13: Overview of pre- and post-transplant diagnosis
Exhibit 14: Global pre-transplant diagnostics market 2015-2020 ($ millions)
Exhibit 15: Global post-transplant diagnostics market 2015-2020 ($ millions)
Exhibit 16: Some reagents, consumables, and instruments available commercially
Exhibit 17: Global transplant diagnostics market by product 2015
Exhibit 18: Global transplant diagnostics market by product 2020
Exhibit 19: Global transplant diagnostics market segmentation by end-user 2015
Exhibit 20: Global transplant diagnostics market segmentation by end-user 2020
Exhibit 21: Global transplant diagnostics market segmentation by application
Exhibit 22: Global transplant diagnostics market segmentation by organ transplantation 2015
Exhibit 23: Global transplant diagnostics market segmentation by organ transplantation 2020
Exhibit 24: Deceased donors for different organs 2015
Exhibit 25: Living donors for different organs 2015
Exhibit 26: Global transplant diagnostics market segmentation by geography 2015
Exhibit 27: Global transplant diagnostics market segmentation by geography 2020
Exhibit 28: Global transplant diagnostics market segmentation by geography 2015-2020
Exhibit 29: Transplant diagnostics market in Americas 2015-2020 ($ millions)
Exhibit 30: Transplant diagnostics market in EMEA 2015-2020 ($ millions)
Exhibit 31: Transplant diagnostics market in APAC 2015-2020 ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Price of sequencers of different companies
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Bio-Rad Laboratories: Product portfolio
Exhibit 36: Bio-Rad Laboratories: Revenue of clinical diagnostics segment 2013-2015 ($ billions)
Exhibit 37: Bio-Rad Laboratories: Key takeaways
Exhibit 38: CareDx: Product portfolio
Exhibit 39: CareDx: AlloSure clinical studies
Exhibit 40: CareDx: Key takeaways
Exhibit 41: Illumina: Product portfolio
Exhibit 42: Illumina: Key takeaways
Exhibit 43: Immucor: Product portfolio
Exhibit 44: Immucor: Revenue of transplant and molecular segment 2013-2015 ($ millions)
Exhibit 45: Immucor: Key takeaways
Exhibit 46: Linkage Biosciences: Product portfolio
Exhibit 47: Linkage Biosciences: Key takeaways
Exhibit 48: Thermo Fisher Scientific: Product portfolio
Exhibit 49: Thermo Fisher Scientific: Revenue of specialty diagnostics segment 2013-2015 ($ billions)
Exhibit 50: Thermo Fisher Scientific: Key takeaways
Exhibit 51: Other prominent vendors

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT